PBYI
Puma Biotechnology
$7.99
+$0.01 (+0.13%)Jul 27, 2026
Key metrics
The numbers that frame PBYI today
- Market cap
- $406.69M
- P/E (TTM)
- 16.7
- EV / FCF
- 7.2
- Gross margin
- 74.5%
- EV / Sales
- 1.7
- ROIC
- 47.9%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $3.03
- 52wk High
- $8.75
Growth
Revenue and earnings trend for PBYI
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PBYI
Is Puma Biotechnology a good buy?
Yes. Puma Biotechnology has excellent quality and excellent momentum. Both signals support the setup. Growth looks weak, a caveat that does not overturn the setup. We think Puma Biotechnology is selling at a low price.
What is the market capitalization of PBYI?
Puma Biotechnology's market capitalization is $406.69M.
What is the P/E ratio for PBYI stock?
Puma Biotechnology's current P/E ratio is 16.7.
What is the 52-week high for PBYI stock?
The 52-week high for Puma Biotechnology is $8.75. The current close of $7.99 is 8.7% below that high.
What is the 52-week low for PBYI stock?
The 52-week low for Puma Biotechnology is $3.03. The current close of $7.99 is 163.7% above that low.
Does PBYI stock pay dividends?
Puma Biotechnology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PBYI?
Puma Biotechnology's Debt / Equity ratio is 0.12.